KAIROS PHARMA LTD (KAPA) Stock Earnings & Estimates
USA - NYSEARCA:KAPA - US48301N1046 - Common Stock
1.76 USD
-0.04 (-2.22%)
1.75 USD
-0.01 (-0.57%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A | N/A | |||||
| EBITDA YoY % growth | -1.845M | -411K 77.72% | -1.554M -278.10% | -2.183M -40.48% | N/A -124.28% | N/A -43.75% | N/A -113.04% | |
| EBIT YoY % growth | -1.943M | -571K 70.61% | -1.714M -200.18% | -2.343M -36.70% | N/A -105.18% | N/A -108.78% | N/A -74.54% | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | N/A | N/A | N/A -20.00% | N/A -52.08% | N/A -39.73% |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | |
|---|---|---|---|---|
| EPS Q2Q % growth | -0.07 32.00% | -0.07 10.75% | -0.10 -27.50% | -0.09 -14.75% |
| Revenue Q2Q % growth | ||||
| EBITDA Q2Q % growth | -2.04M -675.67% | -2.856M -122.08% | N/A | N/A |
| EBIT Q2Q % growth | -864.96K -125.84% | -929.22K 35.74% | -1.694M -33.82% | -1.768M -28.28% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | -0.08 -292.16% | -0.06 | -0.02 | -42.60% |
| Q1 2025 Q2Q % growth | -0.08 -161.44% | -0.05 | -0.03 | -56.86% |
| Q4 2024 Q2Q % growth | -0.08 | -0.04 | -0.04 | -124.09% |
| Q3 2024 Q2Q % growth | -0.10 | -0.02 | -0.08 | -390.20% |
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -11.12% | N/A | 15.29% | 15.29% |
| Revenue | N/A | N/A | N/A | N/A |